Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

STAT3 signaling in prostate cancer progression and therapy resistance: An oncogenic pathway with diverse functions
Mehrdokht Sadrkhanloo, Mahshid Deldar Abad Paskeh, Mehrdad Hashemi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114168-114168
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Targeting the tumor microenvironment, a new therapeutic approach for prostate cancer
Bangwei Fang, Ying Lu, Xiaomeng Li, et al.
Prostate Cancer and Prostatic Diseases (2024)
Closed Access | Times Cited: 11
SLC4A4 is a novel driver of enzalutamide resistance in prostate cancer
Haojie Chen, Mingming Yu, Jiacheng Huang, et al.
Cancer Letters (2024) Vol. 597, pp. 217070-217070
Closed Access | Times Cited: 6
Metabolic reprogramming, malignant transformation and metastasis: lessons from chronic lymphocytic leukaemia and prostate cancer.
Madison T. Hindes, Anthony M. McElligott, Giles Best, et al.
Cancer Letters (2025), pp. 217441-217441
Closed Access
CDCA7 enhances STAT3 transcriptional activity to regulate aerobic glycolysis and promote pancreatic cancer progression and gemcitabine resistance
Dijie Zheng, Yazhu Deng, Lu Deng, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Reversal of chemotherapy resistance in gastric cancer with traditional Chinese medicine as sensitizer: potential mechanism of action
Chencong Zhou, Kaihan Wu, M. Gu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Targeting STAT3 for Cancer Therapy: Focusing on Y705, S727, or Dual Inhibition?
Kyli Berkley, Julian Zalejski, Ashutosh Sharma
Cancers (2025) Vol. 17, Iss. 5, pp. 755-755
Open Access
Targeting and engineering biomarkers for prostate cancer therapy
Dhirodatta Senapati, Santosh Kumar Sahoo, Bhabani Shankar Nayak, et al.
Molecular Aspects of Medicine (2025) Vol. 103, pp. 101359-101359
Closed Access
The olfactory receptor OR51E2 regulates prostate cancer aggressiveness and modulates STAT3 in prostate cancer cells and in xenograft tumors
Mikkel Thy Thomsen, Morten Busk, Dalin Zhang, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Calcium channels as pharmacological targets for cancer therapy
Xiaozhen Liu, Changyun Feng, Yan Li, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
STAT3 Signaling Pathway in Health and Disease
Md Abdus Samad, Iftikhar Ahmad, A. M. Mahedi Hasan, et al.
MedComm (2025) Vol. 6, Iss. 4
Open Access
Updated review on analysis of long non-coding RNAs as emerging diagnostic and therapeutic targets in prostate cancers
Zongpan Ke, Xuechun Hu, Yixun Liu, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104275-104275
Closed Access | Times Cited: 3
Caffeic acid hinders the proliferation and migration through inhibition of IL-6 mediated JAK-STAT-3 signaling axis in human prostate cancer
Yuan Yin, Zhengyin Wang, YUJIE HU, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 12, pp. 1881-1890
Open Access | Times Cited: 3
Enzymatic TET-1 inhibition highlights different epigenetic behaviours of IL-1β and TNFα in tumour progression of OS cell lines
Daniele Bellavia, Salvatore Caruccio, Fabio Caradonna, et al.
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Dysregulated expression of the suppressors of cytokine signaling (SOCS) contributes to the development of prostate cancer
Abdollah Jafarzadeh, Raziyeh Zandvakili, Zahra Jafarzadeh, et al.
Pathology - Research and Practice (2024) Vol. 262, pp. 155558-155558
Closed Access | Times Cited: 2
STAT3 mediates ECM stiffness-dependent progression in ovarian cancer
Chenchen Sun, Qian Xueqian, Yahui Lu, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 1
The Specific ROCK2 Inhibitor KD025 Alleviates Glycolysis through Modulating STAT3-, CSTA- and S1PR3-Linked Signaling in Human Trabecular Meshwork Cells
Megumi Watanabe, Tatsuya Sato, Araya Umetsu, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1165-1165
Open Access | Times Cited: 1
Immunohistochemical analyses reveal FoxP3 expressions in spleen and colorectal cancer in mice treated with AOM/DSS, and their suppression by glycyrrhizin
Guifeng Wang, Keiichi Hiramoto, Ning Ma, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0307038-e0307038
Open Access | Times Cited: 1
Improvement of Docetaxel Efficacy through Simultaneous Blockade of Transcription Factors NF-κB and STAT-3 Using Pentoxifylline and Stattic in Prostate Cancer Cells
José Roberto Cruz-Lozano, Georgina Hernández‐Flores, Pablo César Ortiz-Lazareno, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 9, pp. 10140-10159
Open Access | Times Cited: 1
Reprogramming Tumor-Associated Macrophages: The Role of MEK-STAT3 Inhibition in Lung Cancer
Sushama Rawat, Ehssan Moglad, Muhammad Afzal, et al.
Pathology - Research and Practice (2024) Vol. 265, pp. 155748-155748
Closed Access | Times Cited: 1
Chaga mushroom extract suppresses oral cancer cell growth via inhibition of energy metabolism
Dong-Hyeon Yeo, Yeo Gyun Yun, Seong‐Jin Shin, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
PGC1α as a downstream effector of KDM5B promotes the progression of androgen receptor-positive and androgen receptor-negative prostate cancers
Yuki Teramoto, Zhiming Yang, Takuo Matsukawa, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 9, pp. 4367-4377
Closed Access
pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post‐Initiation of Androgen Deprivation Therapy
Piotr Białas, Tamae Kobayashi, Rebecka Hellsten, et al.
The Prostate (2024)
Open Access
Role of Chemokines and Cytokines in Prostate Cancer Skeletal Metastasis
Yusuke Shiozawa, Keshab R. Parajuli, Kenneth J. Pienta, et al.
Current Osteoporosis Reports (2024) Vol. 23, Iss. 1
Closed Access
Prostate Cancer and WNT/STAT3 Signaling
Sareh Etemad, Mahdokht Sadat Manavi, Mahsa Haji Heidari Varnousafaderani, et al.
(2024), pp. 137-151
Closed Access
Study on the inhibition of non-small cell lung cancer mediated by chitosan-based gene carrier delivering STAT3-shRNA
Wangwang Zhang, Liqiang Song, Yi Zhou, et al.
International Journal of Biological Macromolecules (2024) Vol. 284, pp. 138211-138211
Open Access
Page 1 - Next Page

Scroll to top